Arnulf Dorn

2.9k total citations · 2 hit papers
27 papers, 2.4k citations indexed

About

Arnulf Dorn is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Arnulf Dorn has authored 27 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 14 papers in Molecular Biology and 7 papers in Computational Theory and Mathematics. Recurrent topics in Arnulf Dorn's work include Malaria Research and Control (18 papers), Research on Leishmaniasis Studies (8 papers) and Computational Drug Discovery Methods (7 papers). Arnulf Dorn is often cited by papers focused on Malaria Research and Control (18 papers), Research on Leishmaniasis Studies (8 papers) and Computational Drug Discovery Methods (7 papers). Arnulf Dorn collaborates with scholars based in Switzerland, United States and Australia. Arnulf Dorn's co-authors include Jacques Bollekens, Diane Mathis, Christophe Benoıst, Jonathan L. Vennerstrom, Hugues Matile, Robert G. Ridley, Sudha Rani Vippagunta, C Jaquet, Heinrich Urwyler and Reto Brun and has published in prestigious journals such as Nature, Cell and Journal of Medicinal Chemistry.

In The Last Decade

Arnulf Dorn

27 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A multiplicity of CCAAT box-binding proteins

1987 706 citations Arnulf Dorn et al. profile →
Identification of an antimalarial synthetic trioxolane drug development candidate

2004 507 citations Jonathan L. Vennerstrom, Sarah Arbe‐Barnes et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arnulf Dorn Switzerland	19	1.1k	1.0k	494	438	242	27	2.4k
Kohei Yokoyama United States	30	510 0.5×	1.5k 1.4×	754 1.5×	250 0.6×	269 1.1×	68	2.6k
Dana E. Vanderwall United States	20	459 0.4×	1.3k 1.3×	599 1.2×	367 0.8×	399 1.6×	28	2.2k
Cecília P. Sanchez Germany	30	1.9k 1.8×	587 0.6×	189 0.4×	301 0.7×	588 2.4×	77	2.5k
Michael W. Mather United States	28	1.1k 1.0×	1.6k 1.5×	117 0.2×	208 0.5×	127 0.5×	58	2.8k
G B Henderson United States	10	985 0.9×	501 0.5×	222 0.4×	133 0.3×	182 0.8×	10	1.5k
Bryan T. Mott United States	22	316 0.3×	1.3k 1.2×	370 0.7×	284 0.6×	198 0.8×	44	2.1k
Julie A. Frearson United Kingdom	25	723 0.7×	998 1.0×	707 1.4×	373 0.9×	146 0.6×	43	2.2k
Linda S. Brinen United States	32	849 0.8×	925 0.9×	844 1.7×	169 0.4×	178 0.7×	50	2.7k
Lyann M. B. Ursos United States	13	1.9k 1.8×	293 0.3×	144 0.3×	454 1.0×	678 2.8×	15	2.3k
Timothy E. Benson United States	20	213 0.2×	778 0.8×	237 0.5×	254 0.6×	167 0.7×	27	1.5k

Countries citing papers authored by Arnulf Dorn

Since Specialization

Citations

This map shows the geographic impact of Arnulf Dorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnulf Dorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnulf Dorn more than expected).

Fields of papers citing papers by Arnulf Dorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnulf Dorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnulf Dorn. The network helps show where Arnulf Dorn may publish in the future.

Co-authorship network of co-authors of Arnulf Dorn

This figure shows the co-authorship network connecting the top 25 collaborators of Arnulf Dorn. A scholar is included among the top collaborators of Arnulf Dorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnulf Dorn. Arnulf Dorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Yuanqing, Sergio Wittlin, Susan A. Charman, et al.. (2009). The comparative antimalarial properties of weak base and neutral synthetic ozonides. Bioorganic & Medicinal Chemistry Letters. 20(2). 563–566. 10 indexed citations

Dong, Yuxiang, Sergio Wittlin, K. Sriraghavan, et al.. (2009). The Structure−Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277). Journal of Medicinal Chemistry. 53(1). 481–491. 79 indexed citations

Tang, Yuanqing, Yuxiang Dong, Sergio Wittlin, et al.. (2006). Weak base dispiro-1,2,4-trioxolanes: Potent antimalarial ozonides. Bioorganic & Medicinal Chemistry Letters. 17(5). 1260–1265. 49 indexed citations

Dorn, Arnulf, Andreas Ebneth, Hendrick Bothmann, et al.. (2005). Evaluation of a High-Throughput Fluorescence Assay Method for hERG Potassium Channel Inhibition. SLAS DISCOVERY. 10(4). 339–347. 44 indexed citations

Dorn, Arnulf, et al.. (2005). Subclasses of Simian-Virus-40 Large Tumor Antigen. European Journal of Biochemistry. 128(1). 53–62. 1 indexed citations

Vennerstrom, Jonathan L., Sarah Arbe‐Barnes, Reto Brun, et al.. (2004). Identification of an antimalarial synthetic trioxolane drug development candidate. Nature. 430(7002). 900–904. 507 indexed citations breakdown →

Schlaeger, Ernst‐Jürgen, Eric Kitas, & Arnulf Dorn. (2003). SEAP expression in transiently transfected mammalian cells grown in serum-free suspension culture. Cytotechnology. 42(1). 47–55. 27 indexed citations

Maiti, Souvik, Arnulf Dorn, Bernard Scorneaux, et al.. (2003). Carbon Isosteres of the 4-Aminopyridine Substructure of Chloroquine: Effects on pK_a, Hematin Binding, Inhibition of Hemozoin Formation, and Parasite Growth. Journal of Medicinal Chemistry. 46(14). 3166–3169. 47 indexed citations

Carcache, David A., Paul Seiler, François Diederich, et al.. (2003). Development of a New Class of Inhibitors for the Malarial Aspartic Protease Plasmepsin II Based on a Central 7‐Azabicyclo[2.2.1]heptane Scaffold. Helvetica Chimica Acta. 86(6). 2173–2191. 21 indexed citations

10.

Carcache, David A., Christoph A. Binkert, Daniel Bur, et al.. (2002). De Novo Design, Synthesis, and In Vitro Evaluation of a New Class of Nonpeptidic Inhibitors of the Malarial Enzyme Plasmepsin II. ChemBioChem. 3(11). 1137–1141. 32 indexed citations

11.

Ji, Yuhua, Daniel Bur, Arnulf Dorn, et al.. (2001). Tris-benzimidazole derivatives: design, synthesis and DNA sequence recognition. Bioorganic & Medicinal Chemistry. 9(11). 2905–2919. 32 indexed citations

12.

Vippagunta, Sudha Rani, et al.. (1999). Deferoxamine: Stimulation of hematin polymerization and antagonism of its inhibition by chloroquine. Biochemical Pharmacology. 58(5). 817–824. 21 indexed citations

13.

Vennerstrom, Jonathan L., Edwin O. Nuzum, Robert E. Miller, et al.. (1999). 8-Aminoquinolines Active against Blood Stage Plasmodium falciparum In Vitro Inhibit Hematin Polymerization. Antimicrobial Agents and Chemotherapy. 43(3). 598–602. 80 indexed citations

14.

Vippagunta, Sudha Rani, Arnulf Dorn, Hugues Matile, et al.. (1999). Structural Specificity of Chloroquine−Hematin Binding Related to Inhibition of Hematin Polymerization and Parasite Growth. Journal of Medicinal Chemistry. 42(22). 4630–4639. 129 indexed citations

15.

Dorn, Arnulf, et al.. (1998). A Comparison and Analysis of Several Ways to Promote Haematin (Haem) Polymerisation and an Assessment of Its Initiation In Vitro. Biochemical Pharmacology. 55(6). 737–747. 85 indexed citations

16.

Moon, Richard P., Daniel Bur, Hansruedi Loetscher, et al.. (1998). Studies on Plasmepsins I and II from the Malarial Parasite Plasmodium falciparum and their Exploitation as Drug Targets. Advances in experimental medicine and biology. 436. 397–406. 15 indexed citations

17.

Dorn, Arnulf, Sudha Rani Vippagunta, Hugues Matile, et al.. (1998). An Assessment of Drug-Haematin Binding as a Mechanism for Inhibition of Haematin Polymerisation by Quinoline Antimalarials. Biochemical Pharmacology. 55(6). 727–736. 260 indexed citations

18.

Dorn, Arnulf, Markus Affolter, Walter J. Gehring, & Werner Leupin. (1994). Homeodomain proteins in development and therapy. Pharmacology & Therapeutics. 61(1-2). 155–184. 17 indexed citations

19.

Bannwarth, Willi, et al.. (1994). Short Optimally Capped Duplex DNA as Conformationally Restricted Analogue of B‐DNA. Helvetica Chimica Acta. 77(1). 182–193. 15 indexed citations

20.

Dorn, Arnulf, et al.. (1988). The enhancer in an MHC class II gene, in vitro and in mouso. Biochimie. 70(7). 919–925. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact